NEW YORK (GenomeWeb News) — Research centers at Vanderbilt University and the University of Michigan have joined Sigma-Aldrich’s RNAi Partnership Program, part of the RNAi Consortium, the company said today.
Terms of the membership call for the Vanderbilt-Ingram Cancer and the Comprehensive Cancer Center at the University of Michigan to receive Sigma-Aldrich genomics products, including the TRC shRNA libraries for human and mouse genes, the company said.
Shawn Levy, scientific director of microarray shares resource at the VICC, said the group’s researchers are working on targeted gene-knockdown projects, and said access to the shRNA library will “greatly accelerate their ability to prioritize genes identified from various proteomic and genomic screens."
University of Michigan professor Mikhail Nikiforov said having access to the library is “extremely important for assessing specificity and efficacy of new and existing pharmaceutical agents designed for inhibition of genes and proteins.”
Sigma-Aldrich said it uses its the RNAi Partnership Program to advance functional genomics research by giving academic researchers access to the company’s new technologies and select IP. Other partnering organizations include Washington University, Princeton University, Rutgers University.